Clinical Trials Browser

INDUSTRY × Observational × Non-Muscle Invasive Bladder Neoplasms × Clear all

Non-Muscle Invasive Bladder Neoplasms

NCT07144319 2026-04-01

ENAiBLE

Recruiting

500 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT06026332 2026-02-17

ABLE-41

Terminated

202 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT02660645 2025-12-18

BLCCR

Recruiting

4,400 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT05945108 2025-04-11

Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER

Completed

400 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT05981131 2025-03-13

Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC)

Active not recruiting

6 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT05864599 2024-04-03

EVALUATION

Active not recruiting

600 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT06020807 2023-09-07

Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer

Completed

168 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT03664258 2023-02-13

ANTICIPATE X

Completed

852 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT05508568 2023-02-01

A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

Unknown

650 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT02969109 2021-03-02

Validation of a Urine-based Assay With Genomic Markers for Predicting Recurrence for Non-muscle Invasive Bladder Cancer

Completed

417 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT01314664 2015-06-12

A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC)

Terminated

15 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT01304173 2014-02-19

Retrospective Chart Review of Valstar

Completed

113 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

Clinical Trials

Nova-sTAR

ENAiBLE

ABLE-41

BLCCR

Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER

Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC)

EVALUATION

Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer

ANTICIPATE X

A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

Validation of a Urine-based Assay With Genomic Markers for Predicting Recurrence for Non-muscle Invasive Bladder Cancer

A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC)

Retrospective Chart Review of Valstar